Topics
Glioblastoma | Treatment | Targeted therapy | Sintilimab
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Sintilimab
Lu Y, Liao L, Du K, Mo J, Zou X, Liang J, Chen J, Tang W, Su L, Wu
J, Zhang J, Tan Y.
Clinical activity
and safety of sintilimab, bevacizumab, and TMZ in patients with
recurrent glioblastoma.
BMC
Cancer. 2024 Jan 25;24(1):133. doi:
10.1186/s12885-024-11848-z. PMID:
38273249. Observational study. ˍ